Cover Image
市場調查報告書

鱗狀細胞癌:全球臨床實驗檢討

Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 230794
出版日期 內容資訊 英文 111 Pages
訂單完成後即時交付
價格
Back to Top
鱗狀細胞癌:全球臨床實驗檢討 Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月26日 內容資訊: 英文 111 Pages
簡介

本報告提供鱗狀細胞癌相關的臨床研究最新趨勢分析,彙整疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,地區、Phase、階段別進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑等彙整資訊,為您概述為以下內容。

目錄

簡介

  • 鱗狀細胞癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的前五名國家
    • 歐洲的前五名國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國臨床實驗數量:腫瘤系疾病臨床實驗整體中鱗狀細胞癌的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤系疾病臨床實驗整體中鱗狀細胞癌的比例

E7各國臨床實驗數量:Phase別

E7各國臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 參加鱗狀細胞癌治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Sanofi
    • AstraZeneca PLC
    • Bristol-Myers Squibb Company
    • Novartis AG
    • E. Merck KG
    • Amgen Inc.
    • Merck & Co., Inc.
    • Eli Lilly and Company
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • The University of Texas M. D. Anderson Cancer Center
    • European Organization for Research and Treatment of Cancer
    • Gynecologic Oncology Group
    • Memorial Sloan Kettering Cancer Center
    • Radiation Therapy Oncology Group
    • Roswell Park Cancer Institute
    • Mayo Clinic
    • Stanford University
    • FUDAN University

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2163CTIDB

GlobalData's clinical trial report, "Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Squamous Cell Carcinoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Squamous Cell Carcinoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Squamous Cell Carcinoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Squamous Cell Carcinoma
    • Nov 05, 2013: ImmunoGen Initiates Phase I Testing of Its EGFR-Targeting ADC, IMGN289
    • Sep 09, 2013: Oncolytics Biotech Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer
    • Jul 02, 2013: VentiRx Pharmaceuticals Initiates the ACTIVE8 Phase 2 Clinical Trial Evaluating VTX-2337 in Combination with Cetuximab and Chemotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    • Mar 28, 2013: Oncolytics Biotech Meets Primary Overall Statistical Endpoint In US Phase II Study Of Reolysin In Squamous Cell Lung Cancer
    • Feb 08, 2013: Oncolytics Biotech Announces Additional Positive Reolysin Clinical Trial Data From Phase II Study In Squamous Cell Carcinoma Of Lung
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Gynecologic Oncology Group
      • Clinical Trial Overview of Gynecologic Oncology Group
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • FUDAN University
      • Clinical Trial Overview of FUDAN University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014*

List of Figures

  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top